AI boosts colonoscopy rates in china trial
NCT ID NCT07261059
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether artificial intelligence (AI) can help more high-risk adults aged 40 to 64 get colonoscopies to screen for colorectal cancer. About 400 participants will be split into two groups: one gets usual care, the other gets AI-assisted support from doctors and nurses. The goal is to see if the AI approach increases screening rates and improves people's knowledge about cancer prevention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLONOSCOPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Electric pulses on the wrist may tame colonoscopy pain
- Can delivering cancer drug directly to the liver shrink tumors?
- Peer power: could community education boost cancer screening?
- AI eye for colonoscopy: could software catch what doctors miss?
- One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva
- Could a smartphone photo of stool help detect colon cancer?